-
1 Comment
Longevity Acquisition Corporation is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Longevity Acquisition Corporation's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 69.0% to $-196K since the same quarter in the previous year.
Finally, its free cash flow grew by 66.9% to $-115K since the same quarter in the previous year.
Based on the above factors, Longevity Acquisition Corporation gets an overall score of 3/5.
| ISIN | VGG563721320 |
|---|---|
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Market Cap | 35M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | 0.03 |
Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for LOAC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
